NPC
NVAX icon

National Planning Corporation’s Novavax NVAX Stock Holding History

National Planning Corporation’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-617
Closed -$14K – 420
2017
Q3 		$14K Hold
617
– – ﹤0.01% 680
2017
Q2 		$14K Hold
617
– – ﹤0.01% 736
2017
Q1 		$14K Hold
617
– – ﹤0.01% 705
2016
Q4 		$16K Hold
617
– – ﹤0.01% 690
2016
Q3 		$18K Buy
+617
New +$79.7K ﹤0.01% 650

Other funds holding NVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

National Planning Corporation's NVAX Position: Q4 2017 in Review

National Planning Corporation sold out of Novavax (NVAX) in Q4 2017, closing a stake of 617 shares — an estimated $14K sold.

National Planning Corporation first reported a position in NVAX in Q3 2016 and held it in 5 quarters. The position peaked at $18K in Q3 2016. 135 funds tracked by Wall St. Rank hold NVAX as of Q4 2017.

  • National Planning Corporation reported no remaining Novavax position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 617 Novavax shares in Q4 2017, an estimated $14K.
  • National Planning Corporation first reported a position in Novavax in Q3 2016 and held it in 5 quarters.
  • National Planning Corporation's Novavax position peaked at $18K in Q3 2016.
  • 135 funds tracked by Wall St. Rank held Novavax as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.